Mahesh Swaminathan

17PUBLICATIONS
86CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 26, 2026
Hyper-CVAD Versus Hyper-CVAD Plus Blinatumomab With or Without Inotuzumab Ozogamicin for Adult Patients With Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Propensity-Score Analysis.

|Mar 28, 2026
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes.

Alexandre Bazinet, Alex Bataller, Kelly Chien

|Mar 06, 2026
Performance of molecular scoring systems in hypomethylating agent-treated myelodysplastic neoplasms.

Kelly S Chien, Ziyi Li, Luca Lanino

|Feb 12, 2026
Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Mahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson

|Dec 10, 2025
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia.

Courtney D DiNardo, Wei-Ying Jen, Koichi Takahashi

|Sep 05, 2025
Impact of discordant revised versus molecular international prognostic scoring system risk in myelodysplastic syndrome.

Alexandre Bazinet, Guillermo Montalban-Bravo, Alex Bataller

Pageof 3

Frequent Collaborators

12 joint publications

Tapan M Kadia

11 joint publications

Courtney DiNardo

11 joint publications

Farhad Ravandi

10 joint publications

Elias Jabbour